AI Overview
Evidence suggests that
Insulin-like Growth Factor-1 (IGF-1) in cow’s milk is implicated in the development of certain human cancers (particularly breast and prostate), primarily by increasing the body’s natural levels of IGF-1 rather than through direct absorption of bovine IGF-1. While dairy is not a proven cause of cancer, high circulating IGF-1 is a known risk factor for cell proliferation and inhibited apoptosis (programmed cell death).
Here is the evidence and scientific reasoning linking IGF-1 in milk to cancer:
1. Elevated IGF-1 Levels in Humans
- Milk Intake Increases Serum IGF-1: Studies consistently show that high consumption of cow’s milk and dairy protein raises circulating serum IGF-1 levels in humans.
- Mechanisms of Increase: It is likely not just the absorption of bovine IGF-1 (which has an identical sequence to human IGF-1) that causes the increase, but rather that milk ingredients—specifically high-quality dairy protein and branched-chain amino acids—stimulate the liver to produce more IGF-1.
- Commercial Influences: Dairy cows treated with recombinant bovine somatotropin (rbST) to boost milk yield (a practice banned in the EU but used elsewhere) produce milk with higher levels of IGF-1. Furthermore, mastitis in cows (a common inflammatory disease) increases IGF-1 levels in milk whey.
2. Biological Links to Cancer Development
- Cell Proliferation & Apoptosis Inhibition: IGF-1 is a potent mitogen, meaning it stimulates cell proliferation (growth) and inhibits apoptosis (cell death). In tumors, this promotes growth and progression.
- BRCA1 Interaction: IGF-1 signaling is regulated by the BRCA1 gene. Loss of BRCA1 function—or the presence of certain IGF-1 gain-of-function polymorphisms—can lead to overstimulation by the IGF-1/mTORC1 signaling pathway, increasing susceptibility to breast cancer, particularly ER+ (estrogen receptor-positive) types.
- Synergy with Other Milk Components: IGF-1 in milk acts synergistically with other constituents—such as bovine estrogens, microRNAs, and bovine milk factors—to promote carcinogenesis.
3. Epidemiological and Clinical Findings
- Prostate Cancer: There is moderate evidence linking high milk intake and associated high IGF-1 levels to an increased risk of prostate cancer.
- Breast Cancer: Recent reviews suggest that dairy intake, specifically non-fermented milk, can increase the risk of ER+ breast cancer. Studies often show that milk consumption during puberty can contribute to higher breast density and early menarche, both of which are risk factors for breast cancer.
- Laron Syndrome Evidence: Individuals with Laron syndrome (severe IGF-1 deficiency) rarely develop cancer, suggesting that low levels of this growth factor provide protection against tumor development.
4. Counterpoints and Limitations
- Inconsistent Evidence: While the mechanism is plausible, many epidemiological studies fail to find a strong, consistent relationship between milk intake and cancer, and some studies suggest milk may reduce the risk of colorectal cancer.
- Regulatory Stance: The UK Committee on Carcinogenicity (COC) previously concluded that it was unlikely that intact IGF-1 from dairy is absorbed in significant amounts and that available studies do not show a strong link, although they acknowledge the need for more research.
- Pasteurization: High-temperature pasteurization can destroy part of the IGF-1, though many studies indicate that the stimulation of the liver’s own IGF-1 production still occurs, and many exosomal microRNAs survive pasteurization.
Disclaimer: Dairy products are complex, containing both potentially harmful components (like IGF-1) and beneficial components (like calcium), and the overall impact on cancer risk can vary by individual and cancer type.